β-Adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release

Immunology Letters

Volumn 38, Issue 2, 1993, Pages 127-130

  Monastra, Giovanni ^a   Secchi, Ennio Filippo ^a  

^a Fidia Advanced Biopolymers   (Italy)

Author keywords

Adrenaline; Lipopolysaccharide; Tumor necrosis factor; adrenergic receptor antagonist

Indexed keywords

ADRENALIN; LIPOPOLYSACCHARIDE; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PROPRANOLOL; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPINEPHRINE; LIPOPOLYSACCHARIDES; MICE; PHENTOLAMINE; PROPRANOLOL; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0027331882     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-2478(93)90177-4     Document Type: Article

References (26)

1. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes